Ilika (LON:IKA) Stock Crosses Below 200 Day Moving Average – Time to Sell?

Ilika plc (LON:IKA – Get Free Report)’s share price crossed below its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of GBX 28.36 and traded as low as GBX 22. Ilika shares last traded at GBX 22.33, with a volume of 153,554 shares trading hands.

Ilika Stock Performance

The company has a fifty day moving average price of GBX 23.46 and a two-hundred day moving average price of GBX 28.32. The company has a debt-to-equity ratio of 7.46, a current ratio of 6.31 and a quick ratio of 15.43. The firm has a market cap of £44.35 million, a price-to-earnings ratio of -5.55 and a beta of 2.15.

Ilika (LON:IKA – Get Free Report) last released its quarterly earnings results on Wednesday, July 29th. The company reported GBX (4.02) earnings per share for the quarter. Ilika had a negative net margin of 6,414.98% and a negative return on equity of 45.06%. As a group, equities research analysts expect that Ilika plc will post -5.02 EPS for the current year.

About Ilika

(Get Free Report)

Ilika plc (LON: IKA) is a pioneer in solid state battery technology with their innovative Stereax micro batteries designed for Industrial IoT and MedTech markets, and their Goliath large format batteries for the electric vehicle and consumer electronics markets. Ilika works closely with its ecosystem of partners to provide them with customisable Stereax micro batteries that provide the specific power requirements their IoT or MedTech application requires. Stereax battery technology offers compelling advantages over conventional lithium ion batteries, including smaller footprint, high energy density, non-toxic materials, faster charging, increased cycle life, low leakage and reduced flammability.

See Also

Receive News & Ratings for Ilika Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ilika and related companies with MarketBeat.com's FREE daily email newsletter.